LeMaitre Vascular, Inc. (LMAT) Gains Edge in Niche Vascular Device Market [Yahoo! Finance]
LeMaitre Vascular, Inc. (LMAT)
Last lemaitre vascular, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
lemaitre.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) is a medical device company specializing in products for peripheral vascular disease, affecting over 200 million people worldwide. The company develops and markets disposable and implantable devices used by vascular surgeons, including biologic and biosynthetic grafts, embolectomy and thrombectomy catheters, occlusion and perfusion catheters, and biologic patches for vessel and cardiac repair. Flagship products include the Artegraft biologic graft and Valvulotomes, which support advanced vascular surgeries. In 2025, LeMaitre Vascular, Inc. (NASDAQ:LMAT) showed strong growth, particularly driven by international sales. Q2 2025 results highlighted that Artegraft sales more than doubled quarter-over-quarter outside the U.S., reflecting growing global adoption. The business continues to expand its footprint across the Americas, Europe, the Middle East, Africa, and Asia Pacific, leveraging a direct sales force and distributor network in over 90 coun
Show less
Read more
Impact Snapshot
Event Time:
LMAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LMAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LMAT alerts
High impacting LeMaitre Vascular, Inc. news events
Weekly update
A roundup of the hottest topics
LMAT
News
- LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Is LeMaitre Vascular's Drop an Opportunity After Expansion and Regulatory News? [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular (LMAT): A Fresh Look at Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular (NASDAQ:LMAT) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "buy (b-)" rating to a "hold (c+)" rating.MarketBeat
LMAT
Earnings
- 11/6/25 - Beat
LMAT
Sec Filings
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- LMAT's page on the SEC website